
Fermi Inc. — Investor Relations & Filings
Fermi Inc. is a company developing next-generation electric grids and large-scale artificial intelligence (AI) data center campuses. The company's primary project is an advanced energy and AI campus designed to deliver 11 gigawatts of highly redundant power. This infrastructure utilizes a hybrid energy model that integrates nuclear, natural gas, and solar power generation. Fermi's business model involves leasing data center space and providing dedicated, on-site power to clients with significant computational requirements, such as AI laboratories and cloud providers. By co-locating power generation with data centers, the company aims to directly address the substantial energy demands of the AI sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-22 | English | |
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | |
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | |
| SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-19 | English | |
| SOLICITING MATERIAL UNDER 240.14A-12 | 2026-05-19 | English | |
| SOLICITING MATERIAL PURSUANT TO SECTION 240.14A-12 | 2026-05-18 | English |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46818097 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-22 | English | ||
| 46691536 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | ||
| 46601862 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-20 | English | ||
| 46555844 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-19 | English | ||
| 46555841 | SOLICITING MATERIAL UNDER 240.14A-12 | 2026-05-19 | English | ||
| 46471531 | SOLICITING MATERIAL PURSUANT TO SECTION 240.14A-12 | 2026-05-18 | English | ||
| 46385489 | Preliminary Consent Revocation Statement | 2026-05-18 | English | ||
| 46359945 | 1st Quarter Results | 2026-05-15 | English | ||
| 46351867 | FRMI Q1 2026 FORM 10-Q | 2026-05-14 | English | ||
| 46302389 | SOLICITING MATERIAL PURSUANT TO 240.14A-12A | 2026-05-14 | English | ||
| 45974874 | 1st Quarter Results | 2026-05-14 | English | ||
| 45865322 | Form 8-K | 2026-05-14 | English | ||
| 45955005 | FRMI FORM 8-K FOR Q1 2026 ER | 2026-05-14 | English | ||
| 45954983 | CURRENT REPORT | 2026-05-14 | English | ||
| 44893805 | First Quarter 2026 Earnings Release & Call Date | 2026-05-11 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Viridian Therapeutics, Inc.\DE
Develops antibody-based therapies for serious and rare auto…
|
VRDN | US | Professional, scientific and te… |
|
VITRAFY LIFE SCIENCES LIMITED
Develops advanced cryopreservation and cold chain solutions…
|
VFY | AU | Professional, scientific and te… |
|
Viva Biotech Holdings
Integrated drug discovery, development, and manufacturing s…
|
1873 | KY | Professional, scientific and te… |
|
Viventia Biotech Inc.
Research and development of innovative, targeted oncology t…
|
— | CA | Professional, scientific and te… |
|
Vivo Bio tech Ltd.
Preclinical CRO providing drug discovery services and SPF l…
|
511509 | IN | Professional, scientific and te… |
|
VivoSim Labs, INC.
Develops 3D bioprinted human tissues for non-animal drug to…
|
VIVS | US | Professional, scientific and te… |
|
VOLITIONRX LTD
Epigenetics company developing blood tests for early diagno…
|
VNRX | US | Professional, scientific and te… |
|
Vor Biopharma Inc.
A clinical-stage biotech developing therapies that target t…
|
VOR | US | Professional, scientific and te… |
|
WDB coco CO.,LTD.
A CRO providing support services to the pharmaceutical and …
|
7079 | JP | Professional, scientific and te… |
|
Whitehawk Therapeutics, Inc.
A preclinical oncology company developing advanced antibody…
|
WHWK | US | Professional, scientific and te… |
Fermi Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17756/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17756 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17756 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17756 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17756}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fermi Inc. (id: 17756)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.